Cervical Screening Programme, England - 2012-13 Graphs

Figure 11: Cervical cytology – Percentage of samples from GP & NHS Community Clinics found to be inadequate, for women aged 25-64, by laboratory England, 2012-13
Age 60-64 55-59 50-54 45-49 40-44 35-39 30-34 0.39 0.41 0.45 0.53
0.74
1.07 1.67
25-29
3.08
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 Percent
Source: KC53, Health and Social Care Information Centre.
Number of PCOs 80
60
40
20
4 22 76 49
0 60
65 70 75 80 85 65 70 75 80 85 Coverage (% of eligible population less than 5 years since last adequate test) 60
90
Figure 5: Number of women tested, by age England from 2004-05 to 2012-13
Millions
4.0
3.56
3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
3.28
3.32
25-64 25-49 50-64
2004-05
© Data prior to 2005, re-used with the permission of the Department of Health. Source: KC53, Health and Social Care Information Centre.
Figure 2: Cervical screening – Age appropriate coverage by age group England, at 31st March, 2012 and 2013
England - 97.8 NEYH
North-East North East Yorkshire theHumber Humber Yorkshire && the
97.1
95.9
97.7
North West East Midlands West Midlands East of England London South East South South Central Central
Millions 5.0
4.69
4.5
4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
4.15
4.24
25-64 50-64 25-49
2004-05
2005-06
2006-07
2007-08
2008-09
2009-10
2010-11
2011-12
2012-13
Source: KC53, Health and Social Care Information Centre.
Figure 9: Recall status for women with mild or borderline screening results England, 2011-12 and 2012-13
Percent
Percent
90 80
90 80 70
70.4
Normal (A)
83.6 72.9
Source: KC53, Health and Social Care Information Centre.
Figure 4: Number of women aged 25-64 invited for screening, by age England, 2004-05 to 2012-13
Figure 8: Cervical Screening – Time from screening to receipt of results as measured by expected date of delivery of result letter (eligible women aged 25–64 years), percentage received within 2 weeks: England by reporting region, 2012-13
Other 8.1%
Cervical Cancer 2.5%
CIN2 23.8%
CIN3 or Adenocarcinoma in situ 57.2%
Source: KC61, Health and Social Care Information Centre.
Figure 14: Positive Predictive Value, by laboratory England, April 2012 to June 2012
Figure 13: Outcome of referral following single occurrence of potentially significant abnormality England, April 2012 to June 2012
Non Cervical Cancer 0.5% CIN1 8.0%
50-64 (coverage <5 yrs since last test)
25-49 (coverage <3.5 yrs since last test)
Source: KC53, Health and Social Care Information Centre.
Figure 3: Cervical screening – Five year coverage of the target age group (25-64) Primary Care Organisation (PCO), England, 31st March 2013
Figure 7: Cervical screening – Percentage of tests for women aged 25-64 with an abnormal result England by Primary Care Organisation (PCO), 2012-13
Source: KC53, Health and Social Care Information Centre.
SouthEast East Coast Coast South
98.0
98.0
97.4
99.4 97.6 97.1 97.7 96.6 98.6
70 75
SHA
South West
80
85
90
95
100
Percent
Reporting Region
Source: National Cancer Screening Statistics VSA15 Report, HSCIC ‘Open Exeter’ system (NHAIS).
Percent 100 90 80 70 60 50 40
2012
2013
30 20 10
63.0 62.0 72.7 70.6 76.1 73.7 78.1 75.8 78.3 76.2 82.8 82.4 76.6 75.9 72.7 72.7
0
25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64
Percent 10
9.4
9
8 7 6 5
4
3 2 1 0 2002-03 2003-04 2004-05 2005-06 2006-07 2007-08 2008-09 2009-10 2010-11 2011-12 2012-13
2.2
© Data prior to 2005, re-used with the permission of the Department of Health. Source: KC61, Health and Social Care Information Centre.
20Βιβλιοθήκη Baidu5-06
2006-07
2007-08
2008-09
2009-10
2010-11
2011-12
2012-13
Source: KC53, Health and Social Care Information Centre.
Figure 6: Cervical screening – Test results showing a high-grade abnormality as a percentage of all test results, by age group England 2012-13
Cervical Screening Programme, England, 2012-13: Graphs
Cervical Screening Programme, England, 2012-13: Graphs
1
Figure 1: Cervical screening – Five year coverage of the target age group (25-64) England at 31st March, 2003 to 2013
70
60 50
Repeat (R)
60
50
43.7 33.2 26.0
Suspend (S)
40
30 20 10 0 Borderline changes (2011-12)
3.6
40 30 20
26.1
23.1
10
0
Borderline changes (2012-13)
7.9
1.0
8.5
Mild dyskaryosis (2011-12)
Number of Laboratories 40
35 30 25 20 15 10
5
1 7 55 60 65 70 75 11 80 22 85 34 90 7 95 5 100
0
50 Positive Predictive Value (%)
Source: KC61, Health and Social Care Information Centre.
Cervical Cancer 0.1%
CIN3 or Adenocarcinoma in situ 6.8%
CIN2 10.4%
CIN1 26.3% Other 56.3%
Non Cervical Cancer 0.0%
Source: KC61, Health and Social Care Information Centre.
Number of laboratories
35 30 25
20 15
10 5
6
0 0 1
34
2
27
3
15
4
4
5 6
1
7 8
% Inadequate
Source: KC61, Health and Social Care Information Centre.
Figure 12: Outcome of referral following non-negative test result (persistent or with positive HPV test) England, April 2012 to June 2012
Mild dyskaryosis (2012-13)
Source: KC53, Health and Social Care Information Centre.
Figure 10: Cervical cytology – Percentages of samples from GP & NHS Community Clinics found to be inadequate, from women aged 25-64 England, 2002-03 to 2012-13
Source: KC53, Health and Social Care Information Centre.
Figure 3a: Cervical screening – Five year coverage of the target age group (25-64) Primary Care Organisation, England, 31st March 2013